Base de dados : MEDLINE
Pesquisa : N04.590.374.650 [Categoria DeCS]
Referências encontradas : 46 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 5 ir para página              

  1 / 46 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28470329
[Au] Autor:Ale O; Braimoh RW
[Ad] Endereço:Department of Medicine, Faculty of Clinical Sciences, University of Lagos/Lagos University Teaching Hospital, Lagos, Nigeria. Email: gokeale@yahoo.com.
[Ti] Título:Awareness of hypertension guidelines and the diagnosis and evaluation of hypertension by primary care physicians in Nigeria.
[So] Source:Cardiovasc J Afr;28(2):72-76, 2017 Mar/Apr.
[Is] ISSN:1680-0745
[Cp] País de publicação:South Africa
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: The availability of numerous hypertension guidelines seems not to have impacted significantly on the burden of hypertension. We evaluated awareness of hypertension guidelines among primary-care physicians (PCPs) in Nigeria and its relationship to hypertension diagnosis and work up. METHODS: Anonymous self-administered questionnaires were filled in by PCPs categorised into two groups: hypertension guideline aware (GA) and unaware (GU). RESULTS: The 403 participating PCPs had a mean age and experience of 40 ± 11.34 and 14 ± 11.10 years, respectively, with 46.7% (n = 188) of them being GA. Out of the 19 questions assessed, GA and GU PCPs performed better in seven and two questions, respectively, while the two subgroups had a similar performance in 10 questions. The performance of the PCPs in government and private practice was similar. CONCLUSIONS: There is a gap between guideline recommendations and hypertension care in Nigeria that is further widened by PCPs' unawareness of the guidelines. Popularising hypertension guidelines among PCPs may significantly improve hypertension care and reduce the burden of disease.
[Mh] Termos MeSH primário: Conscientização
Determinação da Pressão Arterial/normas
Pressão Sanguínea
Fidelidade a Diretrizes/normas
Conhecimentos, Atitudes e Prática em Saúde
Hipertensão/diagnóstico
Médicos de Atenção Primária/normas
Guias de Prática Clínica como Assunto/normas
Padrões de Prática Médica/normas
[Mh] Termos MeSH secundário: Adulto
Atitude do Pessoal de Saúde
Feminino
Pesquisas sobre Serviços de Saúde
Seres Humanos
Hipertensão/epidemiologia
Hipertensão/fisiopatologia
Masculino
Meia-Idade
Nigéria/epidemiologia
Médicos de Atenção Primária/psicologia
Valor Preditivo dos Testes
Lacunas da Prática Profissional/normas
Fatores de Risco
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1712
[Cu] Atualização por classe:171218
[Lr] Data última revisão:
171218
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170505
[St] Status:MEDLINE
[do] DOI:10.5830/CVJA-2016-048


  2 / 46 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29029718
[Au] Autor:Sista AK; Moriarty JM
[Ad] Endereço:Division of Interventional Radiology, Langone School of Medicine, New York University, New York, NY.
[Ti] Título:The Future of Catheter-Directed Therapy: Data Gaps, Unmet Needs, and Future Trials.
[So] Source:Tech Vasc Interv Radiol;20(3):224-226, 2017 Sep.
[Is] ISSN:1557-9808
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:This article will focus on 3 avenues for future research: (1) addressing the lack of short- and long-term clinical outcome research on catheter-directed therapy; (2) determining the safety and efficacy of novel thrombus removal devices; and (3) translating our knowledge of the pathobiology and pathophysiology of pulmonary embolism into novel diagnostic and therapeutic strategies.
[Mh] Termos MeSH primário: Cateterismo de Swan-Ganz/tendências
Cateteres/tendências
Ensaios Clínicos como Assunto/métodos
Fibrinolíticos/administração & dosagem
Lacunas da Prática Profissional/tendências
Embolia Pulmonar/terapia
Projetos de Pesquisa/tendências
Terapia Trombolítica/tendências
[Mh] Termos MeSH secundário: Cateterismo de Swan-Ganz/efeitos adversos
Cateterismo de Swan-Ganz/instrumentação
Difusão de Inovações
Desenho de Equipamento
Fibrinolíticos/efeitos adversos
Previsões
Seres Humanos
Infusões Intra-Arteriais
Embolia Pulmonar/diagnóstico
Embolia Pulmonar/fisiopatologia
Fatores de Risco
Terapia Trombolítica/efeitos adversos
Terapia Trombolítica/instrumentação
Resultado do Tratamento
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Fibrinolytic Agents)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171030
[Lr] Data última revisão:
171030
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171015
[St] Status:MEDLINE


  3 / 46 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28847619
[Au] Autor:Biglane JB; Becnel MF; Ventura HO; Krim SR
[Ad] Endereço:Division of Cardiology, John Ochsner Heart and Vascular Institute, New Orleans, LA, United States; Section of Cardiomyopathy & Heart Transplantation, John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, LA, United States.
[Ti] Título:Pharmacologic Therapy for Heart Failure With Reduced Ejection Fraction: Closing the Gap Between Clinical Guidelines and Practice.
[So] Source:Prog Cardiovasc Dis;60(2):187-197, 2017 Sep - Oct.
[Is] ISSN:1873-1740
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Despite the great progress made in the management of heart failure (HF) with reduced ejection fraction (HFrEF), its prevalence continues to rise owing to an aging population and an epidemic of hypertension, obesity and coronary artery disease. For decades, angiotensin converting enzyme inhibitors and beta blockers have been the mainstay of HFrEF therapy. The recent addition of sacubitril/valsartan and ivabradine to the HF armamentarium has the potential to transform our therapeutic approach to HFrEF, while simultaneously raising some questions and uncertainties on their applicability. In this paper, we review the pathophysiology of HFrEF, discuss already established and novel evidenced-based pharmacologic therapies available for these patients. We also share some therapeutic strategies aimed to optimize HF therapy in specific undertreated patient populations including the elderly and patients with chronic kidney disease, while offering insight on how to tailor therapy in the "real-world."
[Mh] Termos MeSH primário: Fármacos Cardiovasculares/uso terapêutico
Insuficiência Cardíaca/tratamento farmacológico
Guias de Prática Clínica como Assunto/normas
Padrões de Prática Médica/normas
Lacunas da Prática Profissional/normas
Volume Sistólico/efeitos dos fármacos
Função Ventricular Esquerda/efeitos dos fármacos
[Mh] Termos MeSH secundário: Fármacos Cardiovasculares/efeitos adversos
Insuficiência Cardíaca/diagnóstico
Insuficiência Cardíaca/mortalidade
Insuficiência Cardíaca/fisiopatologia
Seres Humanos
Seleção de Pacientes
Recuperação de Função Fisiológica
Sistema Renina-Angiotensina/efeitos dos fármacos
Fatores de Risco
Sistema Nervoso Simpático/efeitos dos fármacos
Sistema Nervoso Simpático/fisiopatologia
Resultado do Tratamento
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Cardiovascular Agents)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171023
[Lr] Data última revisão:
171023
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170830
[St] Status:MEDLINE


  4 / 46 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28753518
[Au] Autor:Factor EMR; Matienzo ET; de Guzman AB
[Ad] Endereço:The Graduate School, College of Education, College of Nursing, University of Santo Tomas, Manila 1015, Philippines.
[Ti] Título:A square peg in a round hole: Theory-practice gap from the lens of Filipino student nurses.
[So] Source:Nurse Educ Today;57:82-87, 2017 Oct.
[Is] ISSN:1532-2793
[Cp] País de publicação:Scotland
[La] Idioma:eng
[Ab] Resumo:Previous studies suggest that theory-practice gap has remained to be a formidable task and a challenge to the nursing profession. While efforts to understand the nature and dynamics of theory-practice gap have been undertaken across the globe, a dearth in literature exists in the context of a developing country like the Philippines. Seemingly, no research has ventured yet to explore the theory-practice gap experiences of Filipino student nurses. Hence, the major intent of this qualitative investigation is to describe and capture how theory-practice gap is viewed by a select group of senior nursing students (n=10) in a comprehensive university in the Philippines. From the thickness and richness of the descriptions of the field text gathered in this study, an interesting conceptualization labeled as the Theory-Practice Gap Deficit Triad which consists of (a) structural, (b) pedagogical, and (c) relational deficits was emerged. Interestingly, the said model describes a clear intersection of the various concerns and dilemmas encountered by student nurses in their clinical exposures. Findings of this paper are valuable inputs to nursing educators, practitioners, and administrators in initiating realignment efforts geared toward developing nurses whose knowledge, skills and attitudes are responsive to the ever changing professional practice landscape.
[Mh] Termos MeSH primário: Atitude do Pessoal de Saúde
Competência Clínica
Bacharelado em Enfermagem
Estudantes de Enfermagem/psicologia
[Mh] Termos MeSH secundário: Docentes de Enfermagem
Seres Humanos
Filipinas
Lacunas da Prática Profissional
Pesquisa Qualitativa
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171010
[Lr] Data última revisão:
171010
[Sb] Subgrupo de revista:N
[Da] Data de entrada para processamento:170729
[St] Status:MEDLINE


  5 / 46 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28431865
[Au] Autor:DeCarlo C; Scher L; Shariff S; Phair J; Lipsitz E; Garg K
[Ad] Endereço:Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass.
[Ti] Título:Statin use and other factors associated with mortality after major lower extremity amputation.
[So] Source:J Vasc Surg;66(1):216-225, 2017 Jul.
[Is] ISSN:1097-6809
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVE: Above-knee amputations (AKAs) and below-knee amputations (BKAs) are associated with high postoperative mortality rates. In this study, we examined factors associated with 30-day, 90-day, and 1-year mortality in patients who underwent a major lower extremity amputation. METHODS: We queried a prospectively collected institutional database for all patients who underwent AKA or BKA with primary or secondary closure, during a 5-year period, between November 2009 and November 2014. Predictors of 30- and 90-day mortality were determined by multivariable logistic regression, and risk indexes for 1-year mortality were determined with Cox proportional hazards model. RESULTS: We identified 811 patients who underwent AKA (n = 325) or BKA (n = 486). The 30-day mortality was 8.4% (AKA, 13.5%; BKA, 4.9%; P < .001) and 90-day mortality was 15.4% (AKA, 24.3%; BKA, 9.45%; P < .001). Predictors of 30-day mortality included AKA (odds ratio [OR], 3.09; 95% confidence interval [CI], 1.76-5.53), emergency operation (OR, 2.86; 95% CI, 1.56-5.14), chronic obstructive pulmonary disease (OR, 3.09; 95% CI, 1.07-7.81), end-stage renal disease (ESRD) on hemodialysis (HD; OR, 2.35; 95% CI, 1.24-4.33), and chronic kidney disease stages 3 (OR, 1.84; 95% CI, 1.00-3.37) and 4 (OR, 2.33; 95% CI, 1.01-4.98). Predictors of 90-day mortality included age (OR, 1.02; 95% CI, 1.00-1.04), ESRD on HD (OR, 2.56; 95% CI, 1.55-4.22), AKA (OR, 2.61; 95% CI, 1.70-4.05), history of coronary artery bypass grafting (OR, 2.04; 95% CI, 1.06-3.87), and medium-intensity or high-intensity statin (OR, 0.46; 95% CI, 0.29-0.73). One-year survival for the overall cohort was 73.7% (95% CI, 70.8%-76.8%). Predictors of 1-year mortality included AKA (hazard ratio [HR], 2.07; 95% CI, 1.54-2.77), coronary artery bypass grafting (HR, 1.57; 95% CI, 1.07-2.32), age >70 years (HR, 1.39; 95% CI, 1.02-1.88), gangrene (HR, 1.44; 95% CI, 1.07-1.94), ESRD on HD (HR, 1.96; 95% CI, 1.42-2.70), chronic obstructive pulmonary disease (HR, 2.54; 95% CI, 1.52-4.25), Caucasian race (HR, 1.62; 95% CI, 1.18-2.22), history of open lower extremity revascularization (HR, 0.71; 95% CI, 0.51-1.00) and undergoing bilateral amputations (HR, 2.10; 95% CI, 1.06-4.15). In the year after amputation, medium-intensity statin (HR, 0.64; 95% CI, 0.47-0.87) and high-intensity statin (HR, 0.56; 95% CI, 0.33-0.95) conferred a mortality benefit. Low-intensity statins did not confer protection from mortality. At 1 year after amputation, only 44.7% of patients were receiving appropriate statin therapy. CONCLUSIONS: AKA and BKA have historically been associated with high mortality rates. Medium-intensity and high-intensity statin therapies were associated with a mortality benefit at 1 year. We have identified initiation of statin therapy in this high-risk population as a gap in patient care.
[Mh] Termos MeSH primário: Amputação/mortalidade
Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico
Extremidade Inferior/irrigação sanguínea
Doença Arterial Periférica/cirurgia
[Mh] Termos MeSH secundário: Idoso
Idoso de 80 Anos ou mais
Amputação/efeitos adversos
Comorbidade
Bases de Dados Factuais
Feminino
Fidelidade a Diretrizes
Seres Humanos
Estimativa de Kaplan-Meier
Modelos Logísticos
Masculino
Meia-Idade
Análise Multivariada
Cidade de Nova Iorque
Razão de Chances
Doença Arterial Periférica/diagnóstico
Doença Arterial Periférica/mortalidade
Guias de Prática Clínica como Assunto
Padrões de Prática Médica
Lacunas da Prática Profissional
Modelos de Riscos Proporcionais
Fatores de Proteção
Estudos Retrospectivos
Medição de Risco
Fatores de Risco
Fatores de Tempo
Resultado do Tratamento
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors)
[Em] Mês de entrada:1707
[Cu] Atualização por classe:170713
[Lr] Data última revisão:
170713
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170423
[St] Status:MEDLINE


  6 / 46 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28267469
[Au] Autor:Huffman MD; Mohanan PP; Devarajan R; Baldridge AS; Kondal D; Zhao L; Ali M; Lloyd-Jones DM; Prabhakaran D
[Ad] Endereço:Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. Electronic address: m-huffman@northwestern.edu.
[Ti] Título:Acute coronary syndrome quality improvement in Kerala (ACS QUIK): Rationale and design for a cluster-randomized stepped-wedge trial.
[So] Source:Am Heart J;185:154-160, 2017 Mar.
[Is] ISSN:1097-6744
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Ischemic heart disease is the leading cause of death in India, and there are likely more myocardial infarctions in India than in any other country in the world. We have previously reported heterogeneous care for patients with myocardial infarction in Kerala, a state in southern India, including both gaps in optimal care and inappropriate care. Based on that prior work, limitations from previous nonrandomized quality improvement studies and promising gains in process of care measures demonstrated from previous randomized trials, we and the Cardiological Society of India-Kerala chapter sought to develop, implement, and evaluate a quality improvement intervention to improve process of care measures and clinical outcomes for these patients. In this article, we report the rationale and study design for the ACS QUIK cluster-randomized stepped-wedge clinical trial (NCT02256657) in which we aim to enroll 15,750 participants with acute coronary syndromes across 63 hospitals. To date, most participants are men (76%) and have ST-segment elevation myocardial infarction (63%). The primary outcome is 30-day major adverse cardiovascular events defined as death, recurrent infarction, stroke, or major bleeding. Our secondary outcomes include health-related quality of life and individual- and household-level costs. We also describe the principal features and limitations of the stepped-wedge study design, which may be important for other investigators or sponsors considering cluster-randomized stepped-wedge trials.
[Mh] Termos MeSH primário: Síndrome Coronariana Aguda/terapia
Fidelidade a Diretrizes
Infarto do Miocárdio/terapia
Guias de Prática Clínica como Assunto
Melhoria de Qualidade
[Mh] Termos MeSH secundário: Hemorragia/epidemiologia
Seres Humanos
Índia
Mortalidade
Infarto do Miocárdio/epidemiologia
Avaliação de Processos e Resultados (Cuidados de Saúde)
Lacunas da Prática Profissional
Recidiva
Acidente Vascular Cerebral/epidemiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL
[Em] Mês de entrada:1705
[Cu] Atualização por classe:170531
[Lr] Data última revisão:
170531
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170308
[St] Status:MEDLINE


  7 / 46 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28254849
[Au] Autor:Harrington L
[Ad] Endereço:Linda Harrington is an Independent Consultant, Health Informatics and Digital Strategy, and Professor, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030 (linda.harrington@gmail.com).
[Ti] Título:Closing the Science-Practice Gap With Technology: From Evidence-Based Practice to Practice-Based Evidence.
[So] Source:AACN Adv Crit Care;28(1):12-15, 2017.
[Is] ISSN:1559-7776
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Tecnologia Biomédica
Prática Clínica Baseada em Evidências/métodos
Lacunas da Prática Profissional
Transferência de Tecnologia
Pesquisa Médica Translacional
[Mh] Termos MeSH secundário: Seres Humanos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171010
[Lr] Data última revisão:
171010
[Sb] Subgrupo de revista:N
[Da] Data de entrada para processamento:170304
[St] Status:MEDLINE
[do] DOI:10.4037/aacnacc2017331


  8 / 46 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28078474
[Au] Autor:Tailor J; Fernando D; Sidhu Z; Foley R; Abeysinghe KD; Walsh DC
[Ad] Endereço:Department of Neurosurgery, King's College Hospital, Denmark Hill, London, SE5, UK. jktailor@gmail.com.
[Ti] Título:Clinical audit effectively bridges the evidence-practice gap in chronic subdural haematoma management.
[So] Source:Acta Neurochir (Wien);159(4):627-631, 2017 Apr.
[Is] ISSN:0942-0940
[Cp] País de publicação:Austria
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Placement of a subdural drain after drainage of chronic subdural haematoma (CSDH) has been shown to reduce the rate of recurrence in several randomised controlled trials (RCT). The most recently published RCT was from Cambridge, UK, in 2009. Despite class I evidence for the use of subdural drains, it is unclear whether these results have been translated into clinical practice. In this clinical audit we review the use of subdural drains in our institution before and after the publication of the 2009 RCT results. METHODS: A longitudinal retrospective study was performed on all adults having burr holes for CSDH between January 2009 and January 2014. Case notes were analysed to determine subdural drain use, re-operation for CSDH recurrence and post-operative complications. The audit loop was closed with data collected from August 2015 to January 2016. RESULTS: Thirty-one per cent of patients had subdural drains placed at operation. Drain placement was associated with lower reoperation rates (8% vs. 17%, p = 0.021) without increasing complication rates. Drain usage doubled after publication of the Santarius et al. (2009) trial but we observed persisting and significant variability in drain utilisation by supervising consultants. The use of drains in the department increased from 35% to 75% of all cases after presentation of these results. CONCLUSIONS: The use of subdural drains in our unit reduced recurrence rates following drainage of CSDH and reproduced the results of a 2009 clinical trial. Although the use of subdural drains doubled in the post-trial epoch, significant variability remains in practice. Clinical audit provided an effective tool necessary to drive the implementation of subdural drain placement in our unit.
[Mh] Termos MeSH primário: Auditoria Clínica
Drenagem/efeitos adversos
Medicina Baseada em Evidências/estatística & dados numéricos
Hematoma Subdural Crônico/cirurgia
Complicações Pós-Operatórias/epidemiologia
Lacunas da Prática Profissional/estatística & dados numéricos
Trepanação/efeitos adversos
[Mh] Termos MeSH secundário: Adulto
Drenagem/normas
Medicina Baseada em Evidências/normas
Feminino
Seres Humanos
Masculino
Meia-Idade
Lacunas da Prática Profissional/normas
Reoperação/normas
Reoperação/estatística & dados numéricos
Estudos Retrospectivos
Trepanação/normas
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170927
[Lr] Data última revisão:
170927
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170113
[St] Status:MEDLINE
[do] DOI:10.1007/s00701-016-3063-2


  9 / 46 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28059907
[Au] Autor:McLeod RS
[Ad] Endereço:Toronto, Ontario, Canada.
[Ti] Título:Quality Improvement Initiatives in Colorectal Surgery: Value of Physician Feedback.
[So] Source:Dis Colon Rectum;60(2):133-134, 2017 Feb.
[Is] ISSN:1530-0358
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Cirurgia Colorretal/normas
Retroalimentação
Médicos
Melhoria de Qualidade
[Mh] Termos MeSH secundário: Medicina Baseada em Evidências
Seres Humanos
Auditoria Médica
Guias de Prática Clínica como Assunto
Lacunas da Prática Profissional
Garantia da Qualidade dos Cuidados de Saúde
[Pt] Tipo de publicação:EDITORIAL
[Em] Mês de entrada:1704
[Cu] Atualização por classe:170817
[Lr] Data última revisão:
170817
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170107
[St] Status:MEDLINE
[do] DOI:10.1097/DCR.0000000000000756


  10 / 46 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28031708
[Au] Autor:Lee J; Lee JH; Kim JA; Rhee CK
[Ad] Endereço:Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul.
[Ti] Título:Trend of cost and utilization of COPD medication in Korea.
[So] Source:Int J Chron Obstruct Pulmon Dis;12:27-33, 2017.
[Is] ISSN:1178-2005
[Cp] País de publicação:New Zealand
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: There are only a few longitudinal studies regarding medical utilization and costs for patients with COPD. The purpose of this study was to analyze the trend of medical utilization and costs on a long-term basis. METHODS: Using the Korean Health Insurance Review and Assessment Service (HIRA) data from 2008 to 2013, COPD patients were identified. The trend of medical utilization and costs was also analyzed. RESULTS: The number of COPD patients increased by 13.9% from 2008 to 2013. During the same period, the cost of COPD medication increased by 78.2%. Methylxanthine and systemic beta agonists were most widely prescribed between 2008 and 2013. However, inhaled medications such as long-acting beta-2 agonist (LABA), long-acting muscarinic agonist, and inhaled corticosteroid plus LABA were dispensed to a relatively low proportion of patients with COPD. The number of patients who were prescribed inhaled medications increased gradually from 2008 to 2013, while the number of patients prescribed systemic beta agonist and methylxanthine has decreased since 2010. CONCLUSION: This study shows that there is a large gap between the COPD guidelines and clinical practice in Korea. Training programs for primary care physicians on diagnosis and guideline-based treatment are needed to improve the management of COPD.
[Mh] Termos MeSH primário: Broncodilatadores/administração & dosagem
Broncodilatadores/economia
Custos de Medicamentos/tendências
Recursos em Saúde/economia
Recursos em Saúde/tendências
Padrões de Prática Médica/economia
Padrões de Prática Médica/tendências
Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico
Doença Pulmonar Obstrutiva Crônica/economia
[Mh] Termos MeSH secundário: Administração por Inalação
Corticosteroides/administração & dosagem
Corticosteroides/economia
Agonistas de Receptores Adrenérgicos beta 2/administração & dosagem
Agonistas de Receptores Adrenérgicos beta 2/economia
Bases de Dados Factuais
Combinação de Medicamentos
Prescrições de Medicamentos/economia
Fidelidade a Diretrizes
Recursos em Saúde/utilização
Seres Humanos
Antagonistas Muscarínicos/administração & dosagem
Antagonistas Muscarínicos/economia
Inibidores da Fosfodiesterase 4/administração & dosagem
Inibidores da Fosfodiesterase 4/economia
Guias de Prática Clínica como Assunto
Lacunas da Prática Profissional/economia
Lacunas da Prática Profissional/tendências
Doença Pulmonar Obstrutiva Crônica/diagnóstico
Doença Pulmonar Obstrutiva Crônica/epidemiologia
República da Coreia/epidemiologia
Fatores de Tempo
Resultado do Tratamento
[Pt] Tipo de publicação:COMPARATIVE STUDY; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Adrenal Cortex Hormones); 0 (Adrenergic beta-2 Receptor Agonists); 0 (Bronchodilator Agents); 0 (Drug Combinations); 0 (Muscarinic Antagonists); 0 (Phosphodiesterase 4 Inhibitors)
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170823
[Lr] Data última revisão:
170823
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161230
[St] Status:MEDLINE
[do] DOI:10.2147/COPD.S121687



página 1 de 5 ir para página              
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde